Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217217 · ClinicalTrials.gov registry record · Phase 3
Low Field Magnetic Stimulation Treatment for Bipolar Depression
A Phase 3 study, sponsored by Mclean Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT00217217: Clinical Trial Phase 3 study, sponsored by Mclean Hospital.
NCT00217217 is a Phase 3 study that was terminated before completion, run by Mclean Hospital. The registered enrollment target is 13 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217217, a Phase 3 study, was terminated before completion, sponsored by Mclean Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
Individuals with bipolar depression who had a particular kind of brain imaging reported improved mood after the imaging. This effect may be linked to the changing magnetic fields used during these magnetic resonance imaging studies. The current studies are designed to further explore the important parameters of this effect and to clarify the degree and duration of the mood effects.
Interventions
- DEVICE Echo-Planar Magnetic Resonance Imaging (EP-MRSI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2004-09 |
| Est. Completion | 2012-01 |
| Phase | Phase 3 |
Why NCT00217217 stopped before completion
NCT00217217 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Echo-Planar Magnetic Resonance Imaging (EP-MRSI) is the first listed.
NCT00217217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00217217 about?
NCT00217217 is a clinical study titled "Low Field Magnetic Stimulation Treatment for Bipolar Depression". Individuals with bipolar depression who had a particular kind of brain imaging reported improved mood after the imaging. This effect may be linked to the changing magnetic fields used during these magnetic resonance imaging studies. The current studies are designed to further explore the important p...
What is the current status of trial NCT00217217?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2004-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00217217?
The interventions under investigation include: Echo-Planar Magnetic Resonance Imaging (EP-MRSI) (DEVICE).
Who is sponsoring clinical trial NCT00217217?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00217217's enrollment target sits among peer trials
13 1984th of 2000 higher than 17 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia